Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Testosterone 2% transdermal gel (10mg per actuation) |
BNF code | 0604020K0AABMBM |
Virtual Therapeutic Moiety | Testosterone |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Date of name applicability | 1 Nov 2023 |
Previous name | Testosterone 2% gel (10mg per actuation) |
Basis of previous name | rINN - Recommended International Non-proprietary |
Reason for name change | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 0.500 |
Unit dose form units | gram |
Unit dose unit of measure | actuation |
Virtual Product Ingredient | |
---|---|
Ingredient | Testosterone |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 20.000 |
Strength value numerator unit | mg |
Strength value denominator | 1.000 |
Strength value denominator unit | gram |
Ontology Drug Form & Route | |
Form & Route | gel.transdermal |
Dose Form | |
Formulation | Transdermal gel |
Drug Route | |
Route | Transdermal |
Controlled Drug Prescribing Information | |
Controlled Drug category | Schedule 4 (CD Anab) |
Actual Medicinal Products | |
Tostran 2% gel (Advanz Pharma Germany GmbH) | |
Virtual Medicinal Product Packs | |
Testosterone 2% transdermal gel (10mg per actuation) 180 gram | |
Testosterone 2% transdermal gel (10mg per actuation) 60 gram |
dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.